Transforming growth factor-fîete 1 (tgf-1) promotes il-2 mrna expression through the dp-regulation of nf-kb, ap-1 and nf-at in el4 cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 1105-1112

  Han, Seung H ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MESSENGER RNA; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; CHLORAMPHENICOL ACETYLTRANSFERASE; NUCLEAR FACTOR; NUCLEAR FACTOR AT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN INDUCTION; REGULATORY MECHANISM; RNA ANALYSIS;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032240080     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bellone G, Aste-Amezaga M, Trinchieri G and Rodeck U (1995) Regulation of NK cell functions by TGF-beta. J Immunol 155:1066-1073.
2. Cerwenka A, Bevec D, Majdic O, Knapp W and Holler W (1994) TGF-beta 1 is a potent inducer of human effector T cells. J Immunol 153:4367-4377.
3. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-537.
4. Chomczynski P and Mackey K (1995) Substitution of chloroform with bromochloroproane in the single-step method of RNA isolation. Anal Biochem 225:163-164.
5. Coffman R, Lebman D and Shrader B (1989) Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1039-1044.
6. Condie R, Herring A, Koh W, Lee M and Kaminski N (1996) Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2. J Biol Chem 271:13175-13183.
7. Delaney B, Strom SC, Collins S and Kaminski NE (1994) Carbon tetrachloride suppresses T-cell-dependent immune responses by induction of transforming growth factor-l. Toxicol Appl Pharmacol 126:98-107.
8. Dunnett CW (1955) A multiple comparison procedure for sampling several treatments with a control. J Amer Stat Assoc 50:1096-1121.
9. Ebner R, Chen R-H, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR and Deryrk R ( 1993) Cloning of a type I TGF-/3 receptor and its effect on TGF-/3 binding to the type II receptor. Science (Wash DC) 260:1344-1346.
10. Gilliland G, Perrin K, Blanchard K and Bunn H (1990a) Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sei, USA 87:2725-2729.
11. Gilliland G, Perrin S and Bunn H (1990b) Competitive PCR for quantitation of mRNA, in PCR Protocols: A Guide to Methods and Applications, (Innis MA ed), pp 60-66, Academic Press, Inc., San Diego.
12. Jain J, Miner Z and Rao A (1993) Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J Immunol 151:837-848.
13. Kehrl JH, Thevenin C, Rieckmann P and Fauci AS (1991) Transforming growth factor-0 suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA J Immunol 146:4016-4023.
14. Kehrl J, Wakefield L, Roberts A, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn M and Fauci A (1986) Production of transforming growth factor by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037-1050.
15. Lebman D, Nomura D, Coffman R and Lee F (1990) Molecular characterization cf germ-line immunoglobulin A transcripts produced during transforming growth factor type eta-induced isotype switching. Proc Natl Acad Sei, USA 87:3962 -966.
16. Massague J (1990) The transforming growth factor- family. Annu Rev Cell Biot 6:597-641.
17. Novak TJ, White PM and Rothenberg EV (1990) Regulatory anatomy of the murinu IL-2 gene. Nud Acids Res 18:4523-4533.
18. Ouyang YL, Azcona-Olivera JI and Pestka JJ (1995) Effects of trichothecene struc-ture on cytokine secretion and gene expression in murine CD4+ T cells. Toxicolog;' 104:187-202.
19. Pierce JW, Gifford AM and Baltimore D (1991) Silencing of the expression of the immunoglobulin kappa gene in non-B cells. Mol Cell Biol 11:1431-1437.
20. Pierce JW, Lenardo M and Baltimore D (1988) Oligonucleotide that binds nuclear factor NF-aB acts as a lymphoid-specific and inducible enhancer element. Prof Natl Acad Sei USA 85:1482-1486.
21. Ranges GE, Figari IS, Espevik T and Palladino MA (1987) Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinanl tumor necrosis factor alpha. J Exp Med 166:991-998.
22. Sad S and Mosmann T (1994) Single IL-2-secreting precursor CD4 T cell can develof into either Thl or Th2 cytokine secretion phenotype. J Immunol 153:3514-3522
23. Spaccapelo R, Romani L, Tonnetti L, Cenci E, Mencacci A, Sero G, Tognellini R, Reed S, Puccetti P and Bistoni F (1995) TGF-/3 is important in determining the in vive patterns of susceptibility or resistance in mice infected with Candida albicans. J Immunol 155:1349-1360.
24. Stavnezer J (1995) Regulation of antibody production and class switching by TGFl. J Immunol 155:1647-1651.
25. Swain SL, Huston G, Tonkonogy S and Weinberg A (1991) Transforming growth factor-/3 and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 147:2991-3000.
26. Takahama Y, Letterio JJ, Suzuki H, Farr AG and Singer A (1994) Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing TGF-/3. J Exp Med 179:1495-1506.
27. Vanden Heuvel J, Clark G, Kohn M, Tritscher A, Greenlee W, Lucier G and Bell D (1994) Dioxin-responsive genes: Examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Research 54:62-68.
28. Vanden Heuvel J, Tyson F and Bell D (1993) Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. BioTechniques 14:395-398.
29. Wahl SM, Hunt DA, Wong HL, Dougherty S, McCartney-Francis N, Wahl LM, Ellingsworth L, Schmidt JA, Hall G, Roberts AB and Sporn MB (1988) Transform-ing growth factor-/3 is a potent immunosuppressive agent that inhibits IL-1dependent lymphocyte proliferation. J Immunol 140:3026-3032.
30. Wakefield LM, Smith DM, Masui T, Harris CC and Sporn MB (1987) Distribution and modulation of the cellular receptor for transforming growth factor-oeta. J Cell Biol 105:965-975.
31. Wang T, Li BY, Danielson PD, Lechleider RJ, Martin J, Manganaro T and Donahoe PK (1996) The immunophilin FKBP12 functions as a common inhibitor of the TGF/3 family type I receptors. Cell 86:435-444.
32. Wirth T, Staudt L and Baltimore D (1987) An octamer Oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (Lond) 329:174-178.
33. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X-F and Massague J (1992) TGF-b signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014.
34. Wrana JL, Attisano L, Weisner R, Ventura F and Massague J (1994) Mechanism of activation of the TGF-,8 receptor. Nature (Lond) 370:341-347.
35. Xie Q, Chiles TC and Rothstein TL (1993) Induction of CREE activity via the surface Ig receptor of B cells. J Immunol 151:880-889